Seeking Participants in a Study on Improving Patient/Doctor Communications Concerning Diagnoses of Abnormal Prostate Cells

The University Health Network and The Canadian Cancer Society are seeking volunteers to participate in a study on improving doctor/patient communication about tests or biopsies showing abnormal prostate cells.

The University Health Network and the Canadian Cancer Society are seeking patients who had a biopsy or test showing abnormal cells for a research study.

Background:
Many people have tests and biopsies to confirm or rule out a cancer diagnosis. These tests and biopsies may show abnormal cells with a very low risk of ever turning into cancer. Many patients with these abnormal cells are unclear about whether or not they have cancer, which causes anxiety and reduces the quality of life.

Little prior research has explored how to improve communication about tests or biopsies showing abnormal cells so that patients can better understand their diagnosis, treatment options, and prognosis.

Study purpose: Identify ideal ways to name and discuss abnormal cells by asking patients and doctors about the names they prefer for abnormal cells of the prostate.

You can participate if you:

  • Were 30 years of age or older when diagnosed with abnormal cells
  • Were diagnosed in the last 5 years with abnormal cells by a test or biopsy that your doctor may have referred to as low-risk, stage 0 or pre-cancer, of the following type of Prostate Cancer: o Prostate – referred to as Grade Group 1, detected by a rectal exam, ultrasound or biopsy, managed by repeat tests to see if the abnormal cells change, or by removing the abnormal cells, sometimes along with other types of treatment

What you will be asked to do:

  • Read and sign an online consent form
  • Participate in a single telephone interview of about 20 minutes
  • UHN will ask for your opinion about the words used to name and describe abnormal cells in the prostate

What UHN will give you:

  • After you participate in the telephone interview, UHN will send you compensation
  • When the study is done, UHN will send you a summary of the results

To express interest or ask questions:
The research study is being conducted by Dr. Anna Gagliardi from the University Health Network (UHN) in Toronto with funding from the Canadian Cancer Society. If you are interested in participating or wish to learn more about the study, please contact the study coordinator: The University Health Network and the Canadian Cancer Society are seeking patients who had a biopsy or test showing abnormal cells for a research study.

Background:
Many people have tests and biopsies to confirm or rule out a cancer diagnosis. These tests and biopsies may show abnormal cells with a very low risk of ever turning into cancer. Many patients with these abnormal cells are unclear about whether or not they have cancer, which causes anxiety and reduces the quality of life.

Little prior research has explored how to improve communication about tests or biopsies showing abnormal cells so that patients can better understand their diagnosis, treatment options, and prognosis.

Study purpose: Identify ideal ways to name and discuss abnormal cells by asking patients and doctors about the names they prefer for abnormal cells of the prostate.

You can participate if you:

  • Were 30 years of age or older when diagnosed with abnormal cells
  • Were diagnosed in the last 5 years with abnormal cells by a test or biopsy that your doctor may have referred to as low-risk, stage 0 or pre-cancer, of the following type of Prostate Cancer: o Prostate – referred to as Grade Group 1, detected by a rectal exam, ultrasound or biopsy, managed by repeat tests to see if the abnormal cells change, or by removing the abnormal cells, sometimes along with other types of treatment

What you will be asked to do:

  • Read and sign an online consent form
  • Participate in a single telephone interview of about 20 minutes
  • UHN will ask for your opinion about the words used to name and describe abnormal cells in the prostate

What UHN will give you:

  • After you participate in the telephone interview, UHN will send you compensation
  • When the study is done, UHN will send you a summary of the results

To express interest or ask questions:
The research study is being conducted by Dr. Anna Gagliardi from the University Health Network (UHN) in Toronto with funding from the Canadian Cancer Society. If you are interested in participating or wish to learn more about the study, please contact the study coordinator: .(JavaScript must be enabled to view this email address)